Mylan Wins Argument In Exclusivity Case, But Not Terazosin Approval

Mylan will have to wait until after Feb. 9 to launch its generic terazosin capsules even though the company has won a federal court ruling that Geneva's 180-day exclusivity for the product should have already expired.